SERPINE1, one of the major inhibitors of fibrinolysis (7), was explored and was found to play a positive role in the initiation and progression of cancer types, including gastric adenocarcinoma (10), breast cancer (11), ovarian cancer (23), and lung cancer (24). Here, SERPINE1 is linked to gastric adenocarcinoma.